SCHEMBL6985822

SCHEMBL6985822

COc1ccc(ON2CCCCC2=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
THRB P10828 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
RECQL P46063 1/20 0.49
BLM P54132 1/20 0.49
KMT2A Q03164 1/20 0.49
POLB P06746 1/20 0.47
HPGD P15428 2/20 0.44
HRH3 Q9Y5N1 1/20 0.44
HTT P42858 1/20 0.42
ALDH1A1 P00352 6/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11839130 0.89 ALDH1A1 (0.40) MAPTKDM4EMEN1CYP1A2CYP2D6
SCHEMBL11841829 0.85 CYP1A2 (0.41) MAPTKDM4EMEN1CYP1A2CYP2D6
SCHEMBL1828600 0.77 ALDH1A1 (0.39) MAPTKDM4EMEN1CYP1A2CYP2D6
SCHEMBL611715 0.76 F10 (0.57) MAPTMEN1KMT2APOLBHTT
SCHEMBL608919 0.75 F10 (0.58) MAPTMEN1KMT2APOLBHPGD
SCHEMBL3459387 0.73 L3MBTL1 (0.64) MAPTMEN1KMT2AHRH3ALDH1A1
SCHEMBL2909896 0.73
SCHEMBL20303832 0.72 L3MBTL1 (0.67) MAPTMEN1KMT2AHRH3ALDH1A1
SCHEMBL14169789 0.71 BRD4 (0.39) MAPTKDM4EMEN1CYP1A2CYP2D6
SCHEMBL20042185 0.71 MMP2 (0.65) MAPTKDM4EMEN1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337251-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-08-27 EP claimed
WO-2002102380-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-12-27 WO claimed
EP-1337251-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-08-27 EP disclosed
WO-2002102380-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-12-27 WO disclosed